Shionogi Update: Japan Tobacco Pharma Acquisition Complete

Shionogi & Co., Ltd. announced today the completion of the succession of Japan Tobacco Inc.'s pharmaceutical business. This follows a simplified absorption-type company split.

This completion aligns with previous disclosures made on May 7, 2025, regarding the agreement for the company split of Japan Tobacco's pharmaceutical business and the share transfer of Akros Pharma Inc. Further details were disclosed on September 25, 2025, concerning the progress of the disclosed matters related to the business succession through a company split.

The transaction marks a significant step for Shionogi, as it fully integrates the pharmaceutical division into its operations.